Home
News
Create
Screeners
Insights
Titan Biotech
1,036.
70
+36.60
(+3.66%)
Market Cap
₹856.75 Cr
PE Ratio
35.83
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+3.66%
1M
-4.14%
6M
+144.88%
1Y
+49.82%
5Y
+523.20%
View Company Insights
Latest news about Titan Biotech
Titan Biotech Limited Schedules Board Meeting on February 12, 2026 for Q3FY26 Financial Results
2 hrs ago
Yesterday
Titan Biotech Limited has scheduled a board meeting for February 12, 2026, to consider and approve Q3FY26 unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The meeting will be held at the company's Delhi office. Trading window restrictions remain in effect since January 1, 2026, and will continue until 48 hours after the results declaration, in compliance with SEBI insider trading regulations.
Titan Biotech Limited Reconstitutes Board Committees with New Independent Director Appointments
Jan 03, 2026
Titan Biotech Announces Official Postal Ballot Results with 99.99% Approval
Nov 29, 2025
Titan Biotech Reports Robust Q2 FY2026 Performance with 20% Revenue Growth
Nov 12, 2025
Titan Biotech Reports 8% Revenue Growth and Board Changes in Q1 FY2026
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation